Mesenchymal Stem Cells as Immunomodulators in a Vascularized Composite Allotransplantation

@inproceedings{Kuo2012MesenchymalSC,
  title={Mesenchymal Stem Cells as Immunomodulators in a Vascularized Composite Allotransplantation},
  author={Y R Kuo and Chien-Chang Chen and Shigeru Goto and Pao-Yuan Lin and Fu-Chan Wei and C L Chen},
  booktitle={Clinical & developmental immunology},
  year={2012}
}
Vascularized composite allotransplantations (VCAs) are not routinely performed for tissue reconstruction because of the potentially harmful adverse effects associated with lifelong administration of immunosuppressive agents. Researchers have been eagerly seeking alternative methods that circumvent the long-term use of immunosuppressants. Mesenchymal stem cells (MSCs) show promise as an immunomodulatory therapeutic agent and are currently being tested in preclinical and clinical settings as… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

Exploring cell-based tolerance strategies for hand and face transplantation.

Expert review of clinical immunology • 2015
View 4 Excerpts
Highly Influenced

Mesenchymal Stem Cell Therapy for Ischemic Tissues

Stem cells international • 2018
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 69 references

Management of acute graft-versus-host disease.

British journal of haematology • 2007
View 7 Excerpts
Highly Influenced

Composite tissue transplantation: more science and patience needed.

Plastic and reconstructive surgery • 2001
View 1 Excerpt
Highly Influenced

Graft vasculopathy in clinical hand transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons • 2012
View 1 Excerpt

Similar Papers

Loading similar papers…